Obese patients are at more risk of coming with complications including high blood pressure, type two diabetes, high cholesterol levels, stroke, and certain types of cancer
If youre interested in GLP-1 medication, its better to talk to your doctor about how to move forward
Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies
Without Tesamorelin: Semaglutide creates deficit, body burns mostly subcutaneous fat, belly remains disproportionate
The future may see personalized treatment plans combining GLP-1s with other pharmacological agents, advanced dietary strategies, and behavioral therapies
Neymotin A, Calingasan NY, Wille E, Naseri N, Petri S, Damiano M, et al